Health

    Pandemics & Infectious Diseases

    Pollution

    Medical Treatment & Drug Development

Post-Doctoral Fellowships

United Kingdom

2014.12.31

Mitigating the risks of plasmid mediated antibiotic resistance

To add or modify information on this page, please contact us at the following address: community.research@axa.com

Michelle
BUCKNER

Institution

University of Birmingham

Country

United Kingdom

Nationality

Canadian

ORCID Open Researcher and Contributor ID, a unique and persistent identifier to researchers

Related articles

Health

Pandemics & Infectious Diseases

Chronic & Non Communicable Diseases

AXA Chair

South Africa

2021.11.02

Examining the Relationship Between Syndemics and Societal Change in South Africa

Low- and middle-income countries, particularly those experiencing rapid demographic shifts, are vulnerable to co-occurring pandemics, also known as syndemics, whether... Read more

Lara
DUGAS

University of Cape Town

Health

Medical Treatment & Drug Development

Terresterial Biodiversity

Post-Doctoral Fellowship

Argentina

Harmless and Eco-Friendly Solution as an Alternative to Replace Synthetic Agrochemicals

Agrochemicals were introduced to protect crops from pests and enhance crop yields. However, they have become a long-standing concern due... Read more

Johan
RODRIGUEZ MELO

Instituto de Agrobiotecnología del Litoral

Health

Chronic & Non Communicable Diseases

Women's Health

Pollution

Post-Doctoral Fellowship

Australia

2022.01.31

Assessing the Impacts of Endocrine Disrupting Chemicals (EDCs) On Human Health Using Cutting-Edge Methods

To address this significant public health concern, Dr. Luke Govers and his team have been working with the Environmental Protection... Read more

Luke
GOVERS

University of Melbourne